{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T05:44:34Z","timestamp":1715319874443},"reference-count":193,"publisher":"IntechOpen","license":[{"start":{"date-parts":[[2019,5,17]],"date-time":"2019-05-17T00:00:00Z","timestamp":1558051200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/3.0\/legalcode"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.5772\/intechopen.86285","type":"book-chapter","created":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T07:33:51Z","timestamp":1558942431000},"source":"Crossref","is-referenced-by-count":1,"title":["Myeloid Cells in Multiple Sclerosis"],"prefix":"10.5772","author":[{"given":"Marilyn","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Caryotakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nagendra","family":"Kumar Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athena","family":"M. Soulika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3774","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Goldmann T, Wieghofer P, Jordao MJ, Prutek F, Hagemeyer N, Frenzel K, et\u00a0al. Origin, fate and dynamics of macrophages at central nervous system interfaces. Nature Immunology. 2016;17(7):797-805","DOI":"10.1038\/ni.3423"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Mrdjen D, Pavlovic A, Hartmann FJ, Schreiner B, Utz SG, Leung BP, et\u00a0al. High-dimensional single-cell mapping of central nervous system immune cells reveals distinct myeloid subsets in health, aging, and disease. Immunity. 2018;48(3):599","DOI":"10.1016\/j.immuni.2018.02.014"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Mundt S, Mrdjen D, Utz SG, Greter M, Schreiner B, Becher B.\u00a0Conventional DCs sample and present myelin antigens in the healthy CNS and allow parenchymal T cell entry to initiate neuroinflammation. Science Immunology. 2019;4(31). pii: eaau8380","DOI":"10.1126\/sciimmunol.aau8380"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Herz J, Filiano AJ, Smith A, Yogev N, Kipnis J.\u00a0Myeloid cells in the central nervous system. Immunity. 2017;46(6):943-956","DOI":"10.1016\/j.immuni.2017.06.007"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Nayak D, Roth TL, McGavern DB.\u00a0Microglia development and function. Annual Review of Immunology. 2014;32:367-402","DOI":"10.1146\/annurev-immunol-032713-120240"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Schulz C, Gomez Perdiguero E, Chorro L, Szabo-Rogers H, Cagnard N, Kierdorf K, et\u00a0al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells. Science. 2012;336(6077):86-90","DOI":"10.1126\/science.1219179"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, Gokhan S, et\u00a0al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science. 2010;330(6005):841-845","DOI":"10.1126\/science.1194637"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Kierdorf K, Erny D, Goldmann T, Sander V, Schulz C, Perdiguero EG, et\u00a0al. Microglia emerge from erythromyeloid precursors via Pu.1- and Irf8-dependent pathways. Nature Neuroscience. 2013;16(3):273-280","DOI":"10.1038\/nn.3318"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Rymo SF, Gerhardt H, Wolfhagen Sand F, Lang R, Uv A, Betsholtz C.\u00a0A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One. 2011;6(1):e15846","DOI":"10.1371\/journal.pone.0015846"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Hammond TR, Robinton D, Stevens B.\u00a0Microglia and the brain: Complementary partners in development and disease. Annual Review of Cell and Developmental Biology. 2018;34:523-544","DOI":"10.1146\/annurev-cellbio-100616-060509"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Torres L, Danver J, Ji K, Miyauchi JT, Chen D, Anderson ME, et\u00a0al. Dynamic microglial modulation of spatial learning and social behavior. Brain, Behavior, and Immunity. 2016;55:6-16","DOI":"10.1016\/j.bbi.2015.09.001"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Matcovitch-Natan O, Winter DR, Giladi A, Vargas Aguilar S, Spinrad A, Sarrazin S, et\u00a0al. Microglia development follows a stepwise program to regulate brain homeostasis. Science. 2016;353(6301):aad8670","DOI":"10.1126\/science.aad8670"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Cunningham CL, Martinez-Cerdeno V, Noctor SC.\u00a0Microglia regulate the number of neural precursor cells in the developing cerebral cortex. The Journal of Neuroscience. 2013;33(10):4216-4233","DOI":"10.1523\/JNEUROSCI.3441-12.2013"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Parkhurst CN, Yang G, Ninan I, Savas JN, Yates JR 3rd, Lafaille JJ, et\u00a0al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013;155(7):1596-1609","DOI":"10.1016\/j.cell.2013.11.030"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Paolicelli RC, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P, et\u00a0al. Synaptic pruning by microglia is necessary for normal brain development. Science. 2011;333(6048):1456-1458","DOI":"10.1126\/science.1202529"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et\u00a0al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164-1178","DOI":"10.1016\/j.cell.2007.10.036"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Nandi S, Gokhan S, Dai XM, Wei S, Enikolopov G, Lin H, et\u00a0al. The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. Developmental Biology. 2012;367(2):100-113","DOI":"10.1016\/j.ydbio.2012.03.026"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Kierdorf K, Prinz M.\u00a0Microglia in steady state. The Journal of Clinical Investigation. 2017;127(9):3201-3209","DOI":"10.1172\/JCI90602"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Zhan Y, Paolicelli RC, Sforazzini F, Weinhard L, Bolasco G, Pagani F, et\u00a0al. Deficient neuron-microglia signaling results in impaired functional brain connectivity and social behavior. Nature Neuroscience. 2014;17(3):400-406","DOI":"10.1038\/nn.3641"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Marin-Teva JL, Dusart I, Colin C, Gervais A, van Rooijen N, Mallat M.\u00a0Microglia promote the death of developing Purkinje cells. Neuron. 2004;41(4):535-547","DOI":"10.1016\/S0896-6273(04)00069-8"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Araujo DM, Cotman CW.\u00a0Basic FGF in astroglial, microglial, and neuronal cultures: Characterization of binding sites and modulation of release by lymphokines and trophic factors. The Journal of Neuroscience. 1992;12(5):1668-1678","DOI":"10.1523\/JNEUROSCI.12-05-01668.1992"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Nakajima K, Honda S, Tohyama Y, Imai Y, Kohsaka S, Kurihara T.\u00a0Neurotrophin secretion from cultured microglia. Journal of Neuroscience Research. 2001;65(4):322-331","DOI":"10.1002\/jnr.1157"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Trang T, Beggs S, Salter MW.\u00a0Brain-derived neurotrophic factor from microglia: A molecular substrate for neuropathic pain. Neuron Glia Biology. 2011;7(1):99-108","DOI":"10.1017\/S1740925X12000087"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"De Biase LM, Schuebel KE, Fusfeld ZH, Jair K, Hawes IA, Cimbro R, et\u00a0al. Local cues establish and maintain region-specific phenotypes of basal ganglia microglia. Neuron. 2017;95(2):341-356. e6","DOI":"10.1016\/j.neuron.2017.06.020"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Grabert K, Michoel T, Karavolos MH, Clohisey S, Baillie JK, Stevens MP, et\u00a0al. Microglial brain region-dependent diversity and selective regional sensitivities to aging. Nature Neuroscience. 2016;19(3):504-516","DOI":"10.1038\/nn.4222"},{"key":"ref=26","unstructured":"Butovsky O, Weiner HL.\u00a0Microglial signatures and their role in health and disease. Nature Reviews. Neuroscience. 2018;19(10):622-635"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Hanisch UK.\u00a0Functional diversity of microglia\u2014How heterogeneous are they to begin with? Frontiers in Cellular Neuroscience. 2013;7:65","DOI":"10.3389\/fncel.2013.00065"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Ransohoff RM, Cardona AE.\u00a0The myeloid cells of the central nervous system parenchyma. Nature. 2010;468(7321):253-262","DOI":"10.1038\/nature09615"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, et\u00a0al. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50(1):253-271. e6","DOI":"10.1016\/j.immuni.2018.11.004"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Masuda T, Sankowski R, Staszewski O, Bottcher C, Amann L, Scheiwe C, et\u00a0al. Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution. Nature. 2019;566(7744):388-392","DOI":"10.1038\/s41586-019-0924-x"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Huang Y, Xu Z, Xiong S, Sun F, Qin G, Hu G, et\u00a0al. Repopulated microglia are solely derived from the proliferation of residual microglia after acute depletion. Nature Neuroscience. 2018;21(4):530-540","DOI":"10.1038\/s41593-018-0090-8"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Zhan L, Krabbe G, Du F, Jones I, Reichert MC, Telpoukhovskaia M, et\u00a0al. Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain. PLoS Biology. 2019;17(2):e3000134","DOI":"10.1371\/journal.pbio.3000134"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Cronk JC, Filiano AJ, Louveau A, Marin I, Marsh R, Ji E, et\u00a0al. Peripherally derived macrophages can engraft the brain independent of irradiation and maintain an identity distinct from microglia. The Journal of Experimental Medicine. 2018;215(6):1627-1647","DOI":"10.1084\/jem.20180247"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Chitu V, Gokhan S, Nandi S, Mehler MF, Stanley ER.\u00a0Emerging roles for CSF-1 receptor and its ligands in the nervous system. Trends in Neurosciences. 2016;39(6):378-393","DOI":"10.1016\/j.tins.2016.03.005"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"Wu S, Xue R, Hassan S, Nguyen TML, Wang T, Pan H, et\u00a0al. Il34-Csf1r pathway regulates the migration and colonization of microglial precursors. Developmental Cell. 2018;46(5):552-563 e4","DOI":"10.1016\/j.devcel.2018.08.005"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Buttgereit A, Lelios I, Yu X, Vrohlings M, Krakoski NR, Gautier EL, et\u00a0al. Sall1 is a transcriptional regulator defining microglia identity and function. Nature Immunology. 2016;17(12):1397-1406","DOI":"10.1038\/ni.3585"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"Butovsky O, Jedrychowski MP, Moore CS, Cialic R, Lanser AJ, Gabriely G, et\u00a0al. Identification of a unique TGF-beta-dependent molecular and functional signature in microglia. Nature Neuroscience. 2014;17(1):131-143","DOI":"10.1038\/nn.3599"},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Hickman SE, Kingery ND, Ohsumi TK, Borowsky ML, Wang LC, Means TK, et\u00a0al. The microglial sensome revealed by direct RNA sequencing. Nature Neuroscience. 2013;16(12):1896-1905","DOI":"10.1038\/nn.3554"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Jiang ZH, Peng J, Yang HL, Fu XL, Wang JZ, Liu L, et\u00a0al. Upregulation and biological function of transmembrane protein 119\u00a0in osteosarcoma. Experimental & Molecular Medicine. 2017;49(5):e329","DOI":"10.1038\/emm.2017.41"},{"key":"ref=40","doi-asserted-by":"crossref","unstructured":"Tanaka K, Inoue Y, Hendy GN, Canaff L, Katagiri T, Kitazawa R, et\u00a0al. Interaction of Tmem119 and the bone morphogenetic protein pathway in the commitment of myoblastic into osteoblastic cells. Bone. 2012;51(1):158-167","DOI":"10.1016\/j.bone.2012.04.017"},{"key":"ref=41","doi-asserted-by":"crossref","unstructured":"Tanaka K, Kaji H, Yamaguchi T, Kanazawa I, Canaff L, Hendy GN, et\u00a0al. Involvement of the osteoinductive factors, Tmem119 and BMP-2, and the ER stress response PERK-eIF2alpha-ATF4 pathway in the commitment of myoblastic into osteoblastic cells. Calcified Tissue International. 2014;94(4):454-464","DOI":"10.1007\/s00223-013-9828-1"},{"key":"ref=42","doi-asserted-by":"crossref","unstructured":"Zheng P, Wang W, Ji M, Zhu Q\u2009, Feng Y, Zhou F, et\u00a0al. TMEM119 promotes gastric cancer cell migration and invasion through STAT3 signaling pathway. OncoTargets and Therapy. 2018;11:5835-5844","DOI":"10.2147\/OTT.S164045"},{"key":"ref=43","doi-asserted-by":"crossref","unstructured":"Bachstetter AD, Morganti JM, Jernberg J, Schlunk A, Mitchell SH, Brewster KW, et\u00a0al. Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiology of Aging. 2011;32(11):2030-2044","DOI":"10.1016\/j.neurobiolaging.2009.11.022"},{"key":"ref=44","doi-asserted-by":"crossref","unstructured":"Sellner S, Paricio-Montesinos R, Spiess A, Masuch A, Erny D, Harsan LA, et\u00a0al. Microglial CX3CR1 promotes adult neurogenesis by inhibiting Sirt 1\/p65 signaling independent of CX3CL1. Acta Neuropathologica Communications. 2016;4(1):102","DOI":"10.1186\/s40478-016-0374-8"},{"key":"ref=45","doi-asserted-by":"crossref","unstructured":"Vukovic J, Colditz MJ, Blackmore DG, Ruitenberg MJ, Bartlett PF.\u00a0Microglia modulate hippocampal neural precursor activity in response to exercise and aging. The Journal of Neuroscience. 2012;32(19):6435-6443","DOI":"10.1523\/JNEUROSCI.5925-11.2012"},{"key":"ref=46","doi-asserted-by":"crossref","unstructured":"Fourgeaud L, Traves PG, Tufail Y, Leal-Bailey H, Lew ED, Burrola PG, et\u00a0al. TAM receptors regulate multiple features of microglial physiology. Nature. 2016;532(7598):240-244","DOI":"10.1038\/nature17630"},{"key":"ref=47","doi-asserted-by":"crossref","unstructured":"Hagemeyer N, Hanft KM, Akriditou MA, Unger N, Park ES, Stanley ER, et\u00a0al. Microglia contribute to normal myelinogenesis and to oligodendrocyte progenitor maintenance during adulthood. Acta Neuropathologica. 2017;134(3):441-458","DOI":"10.1007\/s00401-017-1747-1"},{"key":"ref=48","doi-asserted-by":"crossref","unstructured":"Wlodarczyk A, Holtman IR, Krueger M, Yogev N, Bruttger J, Khorooshi R, et\u00a0al. A novel microglial subset plays a key role in myelinogenesis in developing brain. The EMBO Journal. 2017;36(22):3292-3308","DOI":"10.15252\/embj.201696056"},{"key":"ref=49","doi-asserted-by":"crossref","unstructured":"Keaney J, Campbell M.\u00a0The dynamic blood-brain barrier. The FEBS Journal. 2015;282(21):4067-4079","DOI":"10.1111\/febs.13412"},{"key":"ref=50","doi-asserted-by":"crossref","unstructured":"Obermeier B, Daneman R, Ransohoff RM.\u00a0Development, maintenance and disruption of the blood-brain barrier. Nature Medicine. 2013;19(12):1584-1596","DOI":"10.1038\/nm.3407"},{"key":"ref=51","doi-asserted-by":"crossref","unstructured":"Lou N, Takano T, Pei Y, Xavier AL, Goldman SA, Nedergaard M.\u00a0Purinergic receptor P2RY12-dependent microglial closure of the injured blood-brain barrier. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(4):1074-1079","DOI":"10.1073\/pnas.1520398113"},{"key":"ref=52","doi-asserted-by":"crossref","unstructured":"Katsumoto A, Lu H, Miranda AS, Ransohoff RM.\u00a0Ontogeny and functions of central nervous system macrophages. Journal of Immunology. 2014;193(6):2615-2621","DOI":"10.4049\/jimmunol.1400716"},{"key":"ref=53","doi-asserted-by":"crossref","unstructured":"Checchin D, Sennlaub F, Levavasseur E, Leduc M, Chemtob S.\u00a0Potential role of microglia in retinal blood vessel formation. Investigative Ophthalmology & Visual Science. 2006;47(8):3595-3602","DOI":"10.1167\/iovs.05-1522"},{"key":"ref=54","doi-asserted-by":"crossref","unstructured":"Liu C, Wu C, Yang Q\u2009, Gao J, Li L, Yang D, et\u00a0al. Macrophages mediate the repair of brain vascular rupture through direct physical adhesion and mechanical traction. Immunity. 2016;44(5):1162-1176","DOI":"10.1016\/j.immuni.2016.03.008"},{"key":"ref=55","doi-asserted-by":"crossref","unstructured":"Kunis G, Baruch K, Miller O, Schwartz M.\u00a0Immunization with a myelin-derived antigen activates the brain's choroid plexus for recruitment of immunoregulatory cells to the CNS and attenuates disease progression in a mouse model of ALS.\u00a0The Journal of Neuroscience. 2015;35(16):6381-6393","DOI":"10.1523\/JNEUROSCI.3644-14.2015"},{"key":"ref=56","doi-asserted-by":"crossref","unstructured":"Prinz M, Erny D, Hagemeyer N.\u00a0Ontogeny and homeostasis of CNS myeloid cells. Nature Immunology. 2017;18(4):385-392","DOI":"10.1038\/ni.3703"},{"key":"ref=57","doi-asserted-by":"crossref","unstructured":"Reboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, et\u00a0al. C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE.\u00a0Nature Immunology. 2009;10(5):514-523","DOI":"10.1038\/ni.1716"},{"key":"ref=58","doi-asserted-by":"crossref","unstructured":"Zeisel A, Munoz-Manchado AB, Codeluppi S, Lonnerberg P, La Manno G, Jureus A, et\u00a0al. Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq. Science. 2015;347(6226):1138-1142","DOI":"10.1126\/science.aaa1934"},{"key":"ref=59","doi-asserted-by":"crossref","unstructured":"Waskow C, Liu K, Darrasse-Jeze G, Guermonprez P, Ginhoux F, Merad M, et\u00a0al. The receptor tyrosine kinase Flt3 is required for dendritic cell development in peripheral lymphoid tissues. Nature Immunology. 2008;9(6):676-683","DOI":"10.1038\/ni.1615"},{"key":"ref=60","doi-asserted-by":"crossref","unstructured":"Anandasabapathy N, Victora GD, Meredith M, Feder R, Dong B, Kluger C, et\u00a0al. Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain. The Journal of Experimental Medicine. 2011;208(8):1695-1705","DOI":"10.1084\/jem.20102657"},{"key":"ref=61","doi-asserted-by":"crossref","unstructured":"Harpur CM, Kato Y, Dewi ST, Stankovic S, Johnson DN, Bedoui S, et\u00a0al. Classical type 1 dendritic cells dominate priming of Th1 responses to herpes simplex virus type 1 skin infection. Journal of Immunology. 2019;202(3):653-663","DOI":"10.4049\/jimmunol.1800218"},{"key":"ref=62","doi-asserted-by":"crossref","unstructured":"Lee CH, Chen JS, Chiu HC, Hong CH, Liu CY, Ta YC, et\u00a0al. Differential activation behavior of dermal dendritic cells underlies the strain-specific Th1 responses to single epicutaneous immunization. Journal of Dermatological Science. 2016;84(3):248-257","DOI":"10.1016\/j.jdermsci.2016.09.011"},{"key":"ref=63","doi-asserted-by":"crossref","unstructured":"Collin M, Bigley V.\u00a0Human dendritic cell subsets: An update. Immunology. 2018;154(1):3-20","DOI":"10.1111\/imm.12888"},{"key":"ref=64","doi-asserted-by":"crossref","unstructured":"Langlet C, Tamoutounour S, Henri S, Luche H, Ardouin L, Gregoire C, et\u00a0al. CD64 expression distinguishes monocyte-derived and conventional dendritic cells and reveals their distinct role during intramuscular immunization. Journal of Immunology. 2012;188(4):1751-1760","DOI":"10.4049\/jimmunol.1102744"},{"key":"ref=65","unstructured":"Malissen B, Tamoutounour S, Henri S.\u00a0The origins and functions of dendritic cells and macrophages in the skin. Nature Reviews. Immunology. 2014;14(6):417-428"},{"key":"ref=66","doi-asserted-by":"crossref","unstructured":"Theoharides TC.\u00a0Mast cells: The immune gate to the brain. Life Sciences. 1990;46(9):607-617","DOI":"10.1016\/0024-3205(90)90129-F"},{"key":"ref=67","doi-asserted-by":"crossref","unstructured":"Silver R, Curley JP.\u00a0Mast cells on the mind: New insights and opportunities. Trends in Neurosciences. 2013;36(9):513-521","DOI":"10.1016\/j.tins.2013.06.001"},{"key":"ref=68","unstructured":"Kolaczkowska E, Kubes P.\u00a0Neutrophil recruitment and function in health and inflammation. Nature Reviews. Immunology. 2013;13(3):159-175"},{"key":"ref=69","doi-asserted-by":"crossref","unstructured":"Geng S, Matsushima H, Okamoto T, Yao Y, Lu R, Page K, et\u00a0al. Emergence, origin, and function of neutrophil-dendritic cell hybrids in experimentally induced inflammatory lesions in mice. Blood. 2013;121(10):1690-1700","DOI":"10.1182\/blood-2012-07-445197"},{"key":"ref=70","doi-asserted-by":"crossref","unstructured":"Christoffersson G, Vagesjo E, Vandooren J, Liden M, Massena S, Reinert RB, et\u00a0al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood. 2012;120(23):4653-4662","DOI":"10.1182\/blood-2012-04-421040"},{"key":"ref=71","doi-asserted-by":"crossref","unstructured":"Massena S, Christoffersson G, Vagesjo E, Seignez C, Gustafsson K, Binet F, et\u00a0al. Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4\u00a0in mice and humans. Blood. 2015;126(17):2016-2026","DOI":"10.1182\/blood-2015-03-631572"},{"key":"ref=72","doi-asserted-by":"crossref","unstructured":"Tourki B, Halade G.\u00a0Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling. The FASEB Journal. 2017;31(10):4226-4239","DOI":"10.1096\/fj.201700109R"},{"key":"ref=73","doi-asserted-by":"crossref","unstructured":"Cronk JC, Derecki NC, Ji E, Xu Y, Lampano AE, Smirnov I, et\u00a0al. Methyl-CpG binding protein 2 regulates microglia and macrophage gene expression in response to inflammatory stimuli. Immunity. 2015;42(4):679-691","DOI":"10.1016\/j.immuni.2015.03.013"},{"key":"ref=74","doi-asserted-by":"crossref","unstructured":"Frossi B, Mion F, Sibilano R, Danelli L, Pucillo CEM.\u00a0Is it time for a new classification of mast cells? What do we know about mast cell heterogeneity? Immunological Reviews. 2018;282(1):35-46","DOI":"10.1111\/imr.12636"},{"key":"ref=75","doi-asserted-by":"crossref","unstructured":"Irani AM, Schwartz LB.\u00a0Human mast cell heterogeneity. Allergy Proceedings. 1994;15(6):303-308","DOI":"10.2500\/108854194778816472"},{"key":"ref=76","doi-asserted-by":"crossref","unstructured":"Gupta K, Harvima IT.\u00a0Mast cell-neural interactions contribute to pain and itch. Immunological Reviews. 2018;282(1):168-187","DOI":"10.1111\/imr.12622"},{"key":"ref=77","doi-asserted-by":"crossref","unstructured":"Silverman AJ, Asarian L, Khalil M, Silver R.\u00a0GnRH, brain mast cells and behavior. Progress in Brain Research. 2002;141:315-325","DOI":"10.1016\/S0079-6123(02)41102-8"},{"key":"ref=78","doi-asserted-by":"crossref","unstructured":"Theoharides TC, Donelan J, Kandere-Grzybowska K, Konstantinidou A.\u00a0The role of mast cells in migraine pathophysiology. Brain Research. Brain Research Reviews. 2005;49(1):65-76","DOI":"10.1016\/j.brainresrev.2004.11.006"},{"key":"ref=79","doi-asserted-by":"crossref","unstructured":"Crivellato E, Ribatti D.\u00a0The mast cell: An evolutionary perspective. Biological Reviews of the Cambridge Philosophical Society. 2010;85(2):347-360","DOI":"10.1111\/j.1469-185X.2009.00105.x"},{"key":"ref=80","doi-asserted-by":"crossref","unstructured":"Levy D.\u00a0Migraine pain, meningeal inflammation, and mast cells. Current Pain and Headache Reports. 2009;13(3):237-240","DOI":"10.1007\/s11916-009-0040-y"},{"key":"ref=81","doi-asserted-by":"crossref","unstructured":"Chikahisa S, Kodama T, Soya A, Sagawa Y, Ishimaru Y, Sei H, et\u00a0al. Histamine from brain resident MAST cells promotes wakefulness and modulates behavioral states. PLoS One. 2013;8(10):e78434","DOI":"10.1371\/journal.pone.0078434"},{"key":"ref=82","doi-asserted-by":"crossref","unstructured":"Lenz KM, Pickett LA, Wright CL, Davis KT, Joshi A, McCarthy MM.\u00a0Mast cells in the developing brain determine adult sexual behavior. The Journal of Neuroscience. 2018;38(37):8044-8059","DOI":"10.1523\/JNEUROSCI.1176-18.2018"},{"key":"ref=83","doi-asserted-by":"crossref","unstructured":"Wingerchuk DM, Lucchinetti CF, Noseworthy JH.\u00a0Multiple sclerosis: Current pathophysiological concepts. Laboratory Investigation. 2001;81(3):263-281","DOI":"10.1038\/labinvest.3780235"},{"key":"ref=84","doi-asserted-by":"crossref","unstructured":"Lassmann H, Bradl M.\u00a0Multiple sclerosis: Experimental models and reality. Acta Neuropathologica. 2017;133(2):223-244","DOI":"10.1007\/s00401-016-1631-4"},{"key":"ref=85","doi-asserted-by":"crossref","unstructured":"Constantinescu CS, Farooqi N, O\u2019Brien K, Gran B.\u00a0Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS). British Journal of Pharmacology. 2011;164(4):1079-1106","DOI":"10.1111\/j.1476-5381.2011.01302.x"},{"key":"ref=86","doi-asserted-by":"crossref","unstructured":"Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, Pleasure D.\u00a0Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. The Journal of Neuroscience. 2009;29(47):14965-14979","DOI":"10.1523\/JNEUROSCI.3794-09.2009"},{"key":"ref=87","doi-asserted-by":"crossref","unstructured":"Chuluundorj D, Harding SA, Abernethy D, La Flamme AC.\u00a0Expansion and preferential activation of the CD14(+)CD16(+) monocyte subset during multiple sclerosis. Immunology and Cell Biology. 2014;92(6):509-517","DOI":"10.1038\/icb.2014.15"},{"key":"ref=88","doi-asserted-by":"crossref","unstructured":"Gjelstrup MC, Stilund M, Petersen T, Moller HJ, Petersen EL, Christensen T.\u00a0Subsets of activated monocytes and markers of inflammation in incipient and progressed multiple sclerosis. Immunology and Cell Biology. 2018;96(2):160-174","DOI":"10.1111\/imcb.1025"},{"key":"ref=89","doi-asserted-by":"crossref","unstructured":"Karni A, Abraham M, Monsonego A, Cai G, Freeman GJ, Hafler D, et\u00a0al. Innate immunity in multiple sclerosis: Myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response. Journal of Immunology. 2006;177(6):4196-4202","DOI":"10.4049\/jimmunol.177.6.4196"},{"key":"ref=90","doi-asserted-by":"crossref","unstructured":"Nuyts AH, Lee WP, Bashir-Dar R, Berneman ZN, Cools N.\u00a0Dendritic cells in multiple sclerosis: Key players in the immunopathogenesis, key players for new cellular immunotherapies? Multiple Sclerosis. 2013;19(8):995-1002","DOI":"10.1177\/1352458512473189"},{"key":"ref=91","unstructured":"Dendrou CA, Fugger L, Friese MA.\u00a0Immunopathology of multiple sclerosis. Nature Reviews. Immunology. 2015;15(9):545-558"},{"key":"ref=92","doi-asserted-by":"crossref","unstructured":"Popescu BF, Lucchinetti CF.\u00a0Pathology of demyelinating diseases. Annual Review of Pathology. 2012;7:185-217","DOI":"10.1146\/annurev-pathol-011811-132443"},{"key":"ref=93","doi-asserted-by":"crossref","unstructured":"Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H.\u00a0Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Annals of Neurology. 2000;47(6):707-717","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q"},{"key":"ref=94","doi-asserted-by":"crossref","unstructured":"Mahad DH, Trapp BD, Lassmann H.\u00a0Pathological mechanisms in progressive multiple sclerosis. Lancet Neurology. 2015;14(2):183-193","DOI":"10.1016\/S1474-4422(14)70256-X"},{"key":"ref=95","doi-asserted-by":"crossref","unstructured":"Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L.\u00a0Axonal transection in the lesions of multiple sclerosis. The New England Journal of Medicine. 1998;338(5):278-285","DOI":"10.1056\/NEJM199801293380502"},{"key":"ref=96","doi-asserted-by":"crossref","unstructured":"Fischer MT, Sharma R, Lim JL, Haider L, Frischer JM, Drexhage J, et\u00a0al. NADPH oxidase expression in active multiple sclerosis lesions in relation to oxidative tissue damage and mitochondrial injury. Brain. 2012;135(Pt 3):886-899","DOI":"10.1093\/brain\/aws012"},{"key":"ref=97","doi-asserted-by":"crossref","unstructured":"Zrzavy T, Hametner S, Wimmer I, Butovsky O, Weiner HL, Lassmann H.\u00a0Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis. Brain. 2017;140(7):1900-1913","DOI":"10.1093\/brain\/awx113"},{"key":"ref=98","doi-asserted-by":"crossref","unstructured":"Boven LA, Van Meurs M, Van Zwam M, Wierenga-Wolf A, Hintzen RQ\u2009, Boot RG, et\u00a0al. Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain. 2006;129(Pt 2):517-526","DOI":"10.1093\/brain\/awh707"},{"key":"ref=99","doi-asserted-by":"crossref","unstructured":"Fan X, Zhang H, Cheng Y, Jiang X, Zhu J, Jin T.\u00a0Double roles of macrophages in human neuroimmune diseases and their animal models. Mediators of Inflammation. 2016;2016:8489251","DOI":"10.1155\/2016\/8489251"},{"key":"ref=100","doi-asserted-by":"crossref","unstructured":"Gillen KM, Mubarak M, Nguyen TD, Pitt D.\u00a0Significance and in\u00a0vivo detection of iron-laden microglia in white matter multiple sclerosis lesions. Frontiers in Immunology. 2018;9:255","DOI":"10.3389\/fimmu.2018.00255"},{"key":"ref=101","doi-asserted-by":"crossref","unstructured":"Vogel DY, Vereyken EJ, Glim JE, Heijnen PD, Moeton M, van der Valk P, et\u00a0al. Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status. Journal of Neuroinflammation. 2013;10:35","DOI":"10.1186\/1742-2094-10-35"},{"key":"ref=102","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhang ZY, Schittenhelm J, Wu Y, Meyermann R, Schluesener HJ.\u00a0Parenchymal accumulation of CD163+ macrophages\/microglia in multiple sclerosis brains. Journal of Neuroimmunology. 2011;237(1-2):73-79","DOI":"10.1016\/j.jneuroim.2011.06.006"},{"key":"ref=103","doi-asserted-by":"crossref","unstructured":"Giles DA, Washnock-Schmid JM, Duncker PC, Dahlawi S, Ponath G, Pitt D, et\u00a0al. Myeloid cell plasticity in the evolution of central nervous system autoimmunity. Annals of Neurology. 2018;83(1):131-141","DOI":"10.1002\/ana.25128"},{"key":"ref=104","doi-asserted-by":"crossref","unstructured":"Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A, et\u00a0al. Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS One. 2013;8(3):e57573","DOI":"10.1371\/journal.pone.0057573"},{"key":"ref=105","doi-asserted-by":"crossref","unstructured":"Popescu BF, Frischer JM, Webb SM, Tham M, Adiele RC, Robinson CA, et\u00a0al. Pathogenic implications of distinct patterns of iron and zinc in chronic MS lesions. Acta Neuropathologica. 2017;134(1):45-64","DOI":"10.1007\/s00401-017-1696-8"},{"key":"ref=106","doi-asserted-by":"crossref","unstructured":"Hametner S, Wimmer I, Haider L, Pfeifenbring S, Bruck W, Lassmann H.\u00a0Iron and neurodegeneration in the multiple sclerosis brain. Annals of Neurology. 2013;74(6):848-861","DOI":"10.1002\/ana.23974"},{"key":"ref=107","doi-asserted-by":"crossref","unstructured":"Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R.\u00a0Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. Journal of Neuropathology and Experimental Neurology. 2010;69(10):1017-1033","DOI":"10.1097\/NEN.0b013e3181f3a5b1"},{"key":"ref=108","doi-asserted-by":"crossref","unstructured":"Melief J, Schuurman KG, van de Garde MD, Smolders J, van Eijk M, Hamann J, et\u00a0al. Microglia in normal appearing white matter of multiple sclerosis are alerted but immunosuppressed. Glia. 2013;61(11):1848-1861","DOI":"10.1002\/glia.22562"},{"key":"ref=109","doi-asserted-by":"crossref","unstructured":"Singh S, Metz I, Amor S, van der Valk P, Stadelmann C, Bruck W.\u00a0Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons. Acta Neuropathologica. 2013;125(4):595-608","DOI":"10.1007\/s00401-013-1082-0"},{"key":"ref=110","doi-asserted-by":"crossref","unstructured":"Herranz E, Gianni C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, et\u00a0al. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Annals of Neurology. 2016;80(5):776-790","DOI":"10.1002\/ana.24791"},{"key":"ref=111","doi-asserted-by":"crossref","unstructured":"Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, et\u00a0al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology. 2012;79(6):523-530","DOI":"10.1212\/WNL.0b013e3182635645"},{"key":"ref=112","doi-asserted-by":"crossref","unstructured":"Abdelhak A, Weber MS, Tumani H.\u00a0Primary progressive multiple sclerosis: Putting together the puzzle. Frontiers in Neurology. 2017;8:234","DOI":"10.3389\/fneur.2017.00234"},{"key":"ref=113","doi-asserted-by":"crossref","unstructured":"Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM, et\u00a0al. Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain. 2011;134(Pt 9):2755-2771","DOI":"10.1093\/brain\/awr182"},{"key":"ref=114","doi-asserted-by":"crossref","unstructured":"Michailidou I, Naessens DM, Hametner S, Guldenaar W, Kooi EJ, Geurts JJ, et\u00a0al. Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesis. Glia. 2017;65(2):264-277","DOI":"10.1002\/glia.23090"},{"key":"ref=115","doi-asserted-by":"crossref","unstructured":"Shemer A, Grozovski J, Tay TL, Tao J, Volaski A, Suss P, et\u00a0al. Engrafted parenchymal brain macrophages differ from microglia in transcriptome, chromatin landscape and response to challenge. Nature Communications. 2018;9(1):5206","DOI":"10.1038\/s41467-018-07548-5"},{"key":"ref=116","doi-asserted-by":"crossref","unstructured":"Said A, Weindl G.\u00a0Regulation of dendritic cell function in inflammation. Journal of Immunology Research. 2015;2015:743169","DOI":"10.1155\/2015\/743169"},{"key":"ref=117","doi-asserted-by":"crossref","unstructured":"Pierson ER, Wagner CA, Goverman JM.\u00a0The contribution of neutrophils to CNS autoimmunity. Clinical Immunology. 2018;189:23-28","DOI":"10.1016\/j.clim.2016.06.017"},{"key":"ref=118","doi-asserted-by":"crossref","unstructured":"Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et\u00a0al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532-1535","DOI":"10.1126\/science.1092385"},{"key":"ref=119","doi-asserted-by":"crossref","unstructured":"Naegele M, Tillack K, Reinhardt S, Schippling S, Martin R, Sospedra M.\u00a0Neutrophils in multiple sclerosis are characterized by a primed phenotype. Journal of Neuroimmunology. 2012;242(1-2):60-71","DOI":"10.1016\/j.jneuroim.2011.11.009"},{"key":"ref=120","doi-asserted-by":"crossref","unstructured":"Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, Verkman AS, et\u00a0al. Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain. Annals of Neurology. 2012;71(3):323-333","DOI":"10.1002\/ana.22686"},{"key":"ref=121","doi-asserted-by":"crossref","unstructured":"Woodberry T, Bouffler SE, Wilson AS, Buckland RL, Brustle A.\u00a0The emerging role of neutrophil granulocytes in multiple sclerosis. Journal\u00a0of\u00a0Clinical Medicine. 2018;7(12).pii: E511","DOI":"10.3390\/jcm7120511"},{"key":"ref=122","doi-asserted-by":"crossref","unstructured":"Kostic M, Dzopalic T, Zivanovic S, Zivkovic N, Cvetanovic A, Stojanovic I, et\u00a0al. IL-17 and glutamate excitotoxicity in the pathogenesis of multiple sclerosis. Scandinavian Journal of Immunology. 2014;79(3):181-186","DOI":"10.1111\/sji.12147"},{"key":"ref=123","doi-asserted-by":"crossref","unstructured":"Campbell SJ, Meier U, Mardiguian S, Jiang Y, Littleton ET, Bristow A, et\u00a0al. Sickness behaviour is induced by a peripheral CXC-chemokine also expressed in multiple sclerosis and EAE.\u00a0Brain, Behavior, and Immunity. 2010;24(5):738-746","DOI":"10.1016\/j.bbi.2010.01.011"},{"key":"ref=124","doi-asserted-by":"crossref","unstructured":"Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y, et\u00a0al. Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005;128(Pt 5):988-1002","DOI":"10.1093\/brain\/awh453"},{"key":"ref=125","doi-asserted-by":"crossref","unstructured":"Rumble JM, Huber AK, Krishnamoorthy G, Srinivasan A, Giles DA, Zhang X, et\u00a0al. Neutrophil-related factors as biomarkers in EAE and MS.\u00a0The Journal of Experimental Medicine. 2015;212(1):23-35","DOI":"10.1084\/jem.20141015"},{"key":"ref=126","doi-asserted-by":"crossref","unstructured":"Lock C, Hermans G, Pedotti R, Brendolan A, Schadt E, Garren H, et\u00a0al. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nature Medicine. 2002;8(5):500-508","DOI":"10.1038\/nm0502-500"},{"key":"ref=127","doi-asserted-by":"crossref","unstructured":"Burt RK, Fassas A, Snowden J, van Laar JM, Kozak T, Wulffraat NM, et\u00a0al. Collection of hematopoietic stem cells from patients with autoimmune diseases. Bone Marrow Transplantation. 2001;28(1):1-12","DOI":"10.1038\/sj.bmt.1703081"},{"key":"ref=128","doi-asserted-by":"crossref","unstructured":"Openshaw H, Lund BT, Kashyap A, Atkinson R, Sniecinski I, Weiner LP, et\u00a0al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: Report of toxicity and immunological monitoring. Biology of Blood and Marrow Transplantation. 2000;6(5A):563-575","DOI":"10.1016\/S1083-8791(00)70066-8"},{"key":"ref=129","unstructured":"Neumann J.\u00a0Ueber das Vorkommen der sogenannten \u201cMastzellen\u201d bei pathologischen Ver\u00e4nderungen des Gehirns. Archiv f\u00fcr pathologische Anatomie und Physiologie und f\u00fcr klinische Medicin. 1890;122(2):378-308"},{"key":"ref=130","doi-asserted-by":"crossref","unstructured":"Ibrahim MZ, Reder AT, Lawand R, Takash W, Sallouh-Khatib S.\u00a0The mast cells of the multiple sclerosis brain. Journal of Neuroimmunology. 1996;70(2):131-138","DOI":"10.1016\/S0165-5728(96)00102-6"},{"key":"ref=131","doi-asserted-by":"crossref","unstructured":"Olsson Y.\u00a0Mast cells in plaques of multiple sclerosis. Acta Neurologica Scandinavica. 1974;50(5):611-618","DOI":"10.1111\/j.1600-0404.1974.tb02806.x"},{"key":"ref=132","doi-asserted-by":"crossref","unstructured":"Toms R, Weiner HL, Johnson D.\u00a0Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. Journal of Neuroimmunology. 1990;30(2-3):169-177","DOI":"10.1016\/0165-5728(90)90101-R"},{"key":"ref=133","doi-asserted-by":"crossref","unstructured":"Brown MA, Weinberg RB.\u00a0Mast cells and innate lymphoid cells: Underappreciated players in CNS autoimmune demyelinating disease. Frontiers in Immunology. 2018;9:514","DOI":"10.3389\/fimmu.2018.00514"},{"key":"ref=134","doi-asserted-by":"crossref","unstructured":"Calabresi PA, Stone LA, Bash CN, Frank JA, McFarland HF.\u00a0Interferon beta results in immediate reduction of contrast-enhanced MRI lesions in multiple sclerosis patients followed by weekly MRI.\u00a0Neurology. 1997;48(5):1446-1448","DOI":"10.1212\/WNL.48.5.1446"},{"key":"ref=135","doi-asserted-by":"crossref","unstructured":"Jacobs LD, Cookfair DL, Rudick RA, Herndon RM, Richert JR, Salazar AM, et\u00a0al. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Annals of Neurology. 1996;39(3):285-294","DOI":"10.1002\/ana.410390304"},{"key":"ref=136","doi-asserted-by":"crossref","unstructured":"Guarda G, Braun M, Staehli F, Tardivel A, Mattmann C, Forster I, et\u00a0al. Type I interferon inhibits interleukin-1 production and inflammasome activation. Immunity. 2011;34(2):213-223","DOI":"10.1016\/j.immuni.2011.02.006"},{"key":"ref=137","doi-asserted-by":"crossref","unstructured":"Ramgolam VS, Sha Y, Jin J, Zhang X, Markovic-Plese S.\u00a0IFN-beta inhibits human Th17 cell differentiation. Journal of Immunology. 2009;183(8):5418-5427","DOI":"10.4049\/jimmunol.0803227"},{"key":"ref=138","doi-asserted-by":"crossref","unstructured":"Prinz M, Schmidt H, Mildner A, Knobeloch KP, Hanisch UK, Raasch J, et\u00a0al. Distinct and nonredundant in\u00a0vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system. Immunity. 2008;28(5):675-686","DOI":"10.1016\/j.immuni.2008.03.011"},{"key":"ref=139","doi-asserted-by":"crossref","unstructured":"Bustamante MF, Nurtdinov RN, Rio J, Montalban X, Comabella M.\u00a0Baseline gene expression signatures in monocytes from multiple sclerosis patients treated with interferon-beta. PLoS One. 2013;8(4):e60994","DOI":"10.1371\/journal.pone.0060994"},{"key":"ref=140","doi-asserted-by":"crossref","unstructured":"Comabella M, Lunemann JD, Rio J, Sanchez A, Lopez C, Julia E, et\u00a0al. A type I interferon signature in monocytes is associated with poor response to interferon-beta in multiple sclerosis. Brain. 2009;132(Pt 12):3353-3365","DOI":"10.1093\/brain\/awp228"},{"key":"ref=141","doi-asserted-by":"crossref","unstructured":"Zula JA, Green HC, Ransohoff RM, Rudick RA, Stark GR, van Boxel-Dezaire AH.\u00a0The role of cell type-specific responses in IFN-beta therapy of multiple sclerosis. Proceedings of the National Academy of Sciences of the United States of America. 2011;108(49):19689-19694","DOI":"10.1073\/pnas.1117347108"},{"key":"ref=142","unstructured":"Hebb AL, Moore CS, Bhan V, Robertson GS.\u00a0Effects of IFN-B on TRAIL and decoy receptor expression in different immune cell populations from MS patients with distinct disease subtypes. Autoimmune Disease. 2010;2011:485752"},{"key":"ref=143","doi-asserted-by":"crossref","unstructured":"Marckmann S, Wiesemann E, Hilse R, Trebst C, Stangel M, Windhagen A.\u00a0Interferon-beta up-regulates the expression of co-stimulatory molecules CD80, CD86 and CD40 on monocytes: Significance for treatment of multiple sclerosis. Clinical and Experimental Immunology. 2004;138(3):499-506","DOI":"10.1111\/j.1365-2249.2004.02624.x"},{"key":"ref=144","doi-asserted-by":"crossref","unstructured":"Wiesemann E, Deb M, Trebst C, Hemmer B, Stangel M, Windhagen A.\u00a0Effects of interferon-beta on co-signaling molecules: Upregulation of CD40, CD86 and PD-L2 on monocytes in relation to clinical response to interferon-beta treatment in patients with multiple sclerosis. Multiple Sclerosis. 2008;14(2):166-176","DOI":"10.1177\/1352458507081342"},{"key":"ref=145","doi-asserted-by":"crossref","unstructured":"Sellebjerg F, Krakauer M, Limborg S, Hesse D, Lund H, Langkilde A, et\u00a0al. Endogenous and recombinant type I interferons and disease activity in multiple sclerosis. PLoS One. 2012;7(6):e35927","DOI":"10.1371\/journal.pone.0035927"},{"key":"ref=146","doi-asserted-by":"crossref","unstructured":"Gamrekelashvili J, Giagnorio R, Jussofie J, Soehnlein O, Duchene J, Briseno CG, et\u00a0al. Regulation of monocyte cell fate by blood vessels mediated by Notch signalling. Nature Communications. 2016;7:12597","DOI":"10.1038\/ncomms12597"},{"key":"ref=147","doi-asserted-by":"crossref","unstructured":"Adriani M, Nytrova P, Mbogning C, Hassler S, Medek K, Jensen PEH, et\u00a0al. Monocyte NOTCH2 expression predicts IFN-beta immunogenicity in multiple sclerosis patients. JCI Insight. 2018;3(11). pii: 99274","DOI":"10.1172\/jci.insight.99274"},{"key":"ref=148","doi-asserted-by":"crossref","unstructured":"Prod'homme T, Zamvil SS.\u00a0The evolving mechanisms of action of glatiramer acetate. Cold Spring Harbor Perspectives\u00a0in\u00a0Medicine. 2019;9(2). pii: a029249","DOI":"10.1101\/cshperspect.a029249"},{"key":"ref=149","doi-asserted-by":"crossref","unstructured":"Weber MS, Hohlfeld R, Zamvil SS.\u00a0Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics. 2007;4(4):647-653","DOI":"10.1016\/j.nurt.2007.08.002"},{"key":"ref=150","doi-asserted-by":"crossref","unstructured":"Fridkis-Hareli M, Teitelbaum D, Gurevich E, Pecht I, Brautbar C, Kwon OJ, et\u00a0al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells\u2014Specificity and promiscuity. Proceedings of the National Academy of Sciences of the United States of America. 1994;91(11):4872-4876","DOI":"10.1073\/pnas.91.11.4872"},{"key":"ref=151","doi-asserted-by":"crossref","unstructured":"Teitelbaum D, Fridkis-Hareli M, Arnon R, Sela M.\u00a0Copolymer 1 inhibits chronic relapsing experimental allergic encephalomyelitis induced by proteolipid protein (PLP) peptides in mice and interferes with PLP-specific T cell responses. Journal of Neuroimmunology. 1996;64(2):209-217","DOI":"10.1016\/0165-5728(95)00180-8"},{"key":"ref=152","doi-asserted-by":"crossref","unstructured":"Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, Lee L, et\u00a0al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nature Medicine. 2007;13(8):935-943","DOI":"10.1038\/nm1620"},{"key":"ref=153","doi-asserted-by":"crossref","unstructured":"Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, Lapierre Y, et\u00a0al. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. Journal of Immunology. 2004;172(11):7144-7153","DOI":"10.4049\/jimmunol.172.11.7144"},{"key":"ref=154","doi-asserted-by":"crossref","unstructured":"Chuluundorj D, Harding SA, Abernethy D, La Flamme AC.\u00a0Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls. Immunology and Cell Biology. 2017;95(3):297-305","DOI":"10.1038\/icb.2016.99"},{"key":"ref=155","doi-asserted-by":"crossref","unstructured":"Hussien Y, Sanna A, Soderstrom M, Link H, Huang YM.\u00a0Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. Journal of Neuroimmunology. 2001;121(1-2):102-110","DOI":"10.1016\/S0165-5728(01)00432-5"},{"key":"ref=156","doi-asserted-by":"crossref","unstructured":"Sellebjerg F, Hesse D, Limborg S, Lund H, Sondergaard HB, Krakauer M, et\u00a0al. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis. Multiple Sclerosis. 2013;19(2):179-187","DOI":"10.1177\/1352458512450353"},{"key":"ref=157","doi-asserted-by":"crossref","unstructured":"van der Touw W, Kang K, Luan Y, Ma G, Mai S, Qin L, et\u00a0al. Glatiramer acetate enhances myeloid-derived suppressor cell function via recognition of paired Ig-like receptor B.\u00a0Journal of Immunology. 2018;201(6):1727-1734","DOI":"10.4049\/jimmunol.1701450"},{"key":"ref=158","doi-asserted-by":"crossref","unstructured":"Mindur JE, Valenzuela RM, Yadav SK, Boppana S, Dhib-Jalbut S, Ito K.\u00a0IL-27: A potential biomarker for responders to glatiramer acetate therapy. Journal of Neuroimmunology. 2017;304:21-28","DOI":"10.1016\/j.jneuroim.2016.07.004"},{"key":"ref=159","doi-asserted-by":"crossref","unstructured":"Lalive PH, Kreutzfeldt M, Devergne O, Metz I, Bruck W, Merkler D, et\u00a0al. Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients. Journal of Neuroinflammation. 2017;14(1):144","DOI":"10.1186\/s12974-017-0919-1"},{"key":"ref=160","doi-asserted-by":"crossref","unstructured":"Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, et\u00a0al. Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. The New England Journal of Medicine. 2010;362(5):402-415","DOI":"10.1056\/NEJMoa0907839"},{"key":"ref=161","doi-asserted-by":"crossref","unstructured":"Chun J, Kihara Y, Jonnalagadda D, Blaho VA.\u00a0Fingolimod: Lessons learned and new opportunities for treating multiple sclerosis and other disorders. Annual Review of Pharmacology and Toxicology. 2019;59:149-170","DOI":"10.1146\/annurev-pharmtox-010818-021358"},{"key":"ref=162","doi-asserted-by":"crossref","unstructured":"Brinkmann V, Billich A, Baumruker T, Heining P, Schmouder R, Francis G, et\u00a0al. Fingolimod (FTY720): Discovery and development of an oral drug to treat multiple sclerosis. Nature Reviews. Drug Discovery. 2010;9(11):883-897","DOI":"10.1038\/nrd3248"},{"key":"ref=163","doi-asserted-by":"crossref","unstructured":"Di Dario M, Colombo E, Govi C, De Feo D, Messina MJ, Romeo M, et\u00a0al. Myeloid cells as target of fingolimod action in multiple sclerosis. Neurology:\u00a0Neuroimmunology\u00a0&\u00a0Neuroinflammation. 2015;2(6):e157","DOI":"10.1212\/NXI.0000000000000157"},{"key":"ref=164","doi-asserted-by":"crossref","unstructured":"Durafourt BA, Lambert C, Johnson TA, Blain M, Bar-Or A, Antel JP.\u00a0Differential responses of human microglia and blood-derived myeloid cells to FTY720. Journal of Neuroimmunology. 2011;230(1-2):10-16","DOI":"10.1016\/j.jneuroim.2010.08.006"},{"key":"ref=165","doi-asserted-by":"crossref","unstructured":"Hughes JE, Srinivasan S, Lynch KR, Proia RL, Ferdek P, Hedrick CC.\u00a0Sphingosine-1-phosphate induces an antiinflammatory phenotype in macrophages. Circulation Research. 2008;102(8):950-958","DOI":"10.1161\/CIRCRESAHA.107.170779"},{"key":"ref=166","doi-asserted-by":"crossref","unstructured":"Thomas K, Sehr T, Proschmann U, Rodriguez-Leal FA, Haase R, Ziemssen T.\u00a0Fingolimod additionally acts as immunomodulator focused on the innate immune system beyond its prominent effects on lymphocyte recirculation. Journal of Neuroinflammation. 2017;14(1):41","DOI":"10.1186\/s12974-017-0817-6"},{"key":"ref=167","doi-asserted-by":"crossref","unstructured":"Michell-Robinson MA, Moore CS, Healy LM, Osso LA, Zorko N, Grouza V, et\u00a0al. Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis. Annals of Clinical Translational Neurology. 2016;3(1):27-41","DOI":"10.1002\/acn3.270"},{"key":"ref=168","doi-asserted-by":"crossref","unstructured":"Foster CA, Howard LM, Schweitzer A, Persohn E, Hiestand PC, Balatoni B, et\u00a0al. Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis. The Journal of Pharmacology and Experimental Therapeutics. 2007;323(2):469-475","DOI":"10.1124\/jpet.107.127183"},{"key":"ref=169","doi-asserted-by":"crossref","unstructured":"Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, et\u00a0al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 2011;134(Pt 3):678-692","DOI":"10.1093\/brain\/awq386"},{"key":"ref=170","doi-asserted-by":"crossref","unstructured":"Mills EA, Ogrodnik MA, Plave A, Mao-Draayer Y.\u00a0Emerging understanding of the mechanism of action for dimethyl fumarate in the treatment of multiple sclerosis. Frontiers in Neurology. 2018;9:5","DOI":"10.3389\/fneur.2018.00005"},{"key":"ref=171","doi-asserted-by":"crossref","unstructured":"Paraiso HC, Kuo PC, Curfman ET, Moon HJ, Sweazey RD, Yen JH, et\u00a0al. Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge. Journal of Neuroinflammation. 2018;15(1):100","DOI":"10.1186\/s12974-018-1125-5"},{"key":"ref=172","doi-asserted-by":"crossref","unstructured":"Schulze-Topphoff U, Varrin-Doyer M, Pekarek K, Spencer CM, Shetty A, Sagan SA, et\u00a0al. Dimethyl fumarate treatment induces adaptive and innate immune modulation independent of Nrf2. Proceedings of the National Academy of Sciences of the United States of America. 2016;113(17):4777-4782","DOI":"10.1073\/pnas.1603907113"},{"key":"ref=173","doi-asserted-by":"crossref","unstructured":"Schilling S, Goelz S, Linker R, Luehder F, Gold R.\u00a0Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clinical and Experimental Immunology. 2006;145(1):101-107","DOI":"10.1111\/j.1365-2249.2006.03094.x"},{"key":"ref=174","doi-asserted-by":"crossref","unstructured":"Bar-Or A, Pachner A, Menguy-Vacheron F, Kaplan J, Wiendl H.\u00a0Teriflunomide and its mechanism of action in multiple sclerosis. Drugs. 2014;74(6):659-674","DOI":"10.1007\/s40265-014-0212-x"},{"key":"ref=175","doi-asserted-by":"crossref","unstructured":"Bar-Or A.\u00a0Teriflunomide (Aubagio(R)) for the treatment of multiple sclerosis. Experimental\u00a0Neurology. 2014;262(Pt A):57-65","DOI":"10.1016\/j.expneurol.2014.06.005"},{"key":"ref=176","doi-asserted-by":"crossref","unstructured":"Merrill JE, Hanak S, Pu SF, Liang J, Dang C, Iglesias-Bregna D, et\u00a0al. Teriflunomide reduces behavioral, electrophysiological, and histopathological deficits in the Dark Agouti rat model of experimental autoimmune encephalomyelitis. Journal of Neurology. 2009;256(1):89-103","DOI":"10.1007\/s00415-009-0075-3"},{"key":"ref=177","doi-asserted-by":"crossref","unstructured":"Wostradowski T, Prajeeth CK, Gudi V, Kronenberg J, Witte S, Brieskorn M, et\u00a0al. In vitro evaluation of physiologically relevant concentrations of teriflunomide on activation and proliferation of primary rodent microglia. Journal of Neuroinflammation. 2016;13(1):250","DOI":"10.1186\/s12974-016-0715-3"},{"key":"ref=178","doi-asserted-by":"crossref","unstructured":"Li L, Liu J, Delohery T, Zhang D, Arendt C, Jones C.\u00a0The effects of teriflunomide on lymphocyte subpopulations in human peripheral blood mononuclear cells in\u00a0vitro. Journal of Neuroimmunology. 2013;265(1-2):82-90","DOI":"10.1016\/j.jneuroim.2013.10.003"},{"key":"ref=179","doi-asserted-by":"crossref","unstructured":"Medina S, Sainz de la Maza S, Villarrubia N, Alvarez-Lafuente R, Costa-Frossard L, Arroyo R, et\u00a0al. Teriflunomide induces a tolerogenic bias in blood immune cells of MS patients. Annals of Clinical Translational Neurology. 2019;6(2):355-363","DOI":"10.1002\/acn3.711"},{"key":"ref=180","doi-asserted-by":"crossref","unstructured":"Polman CH, O'Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, et\u00a0al. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. The New England Journal of Medicine. 2006;354(9):899-910","DOI":"10.1056\/NEJMoa044397"},{"key":"ref=181","doi-asserted-by":"crossref","unstructured":"Planas R, Jelcic I, Schippling S, Martin R, Sospedra M.\u00a0Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis. European Journal of Immunology. 2012;42(3):790-798","DOI":"10.1002\/eji.201142108"},{"key":"ref=182","doi-asserted-by":"crossref","unstructured":"Metz I, Radue EW, Oterino A, Kumpfel T, Wiendl H, Schippling S, et\u00a0al. Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy. Acta Neuropathologica. 2012;123(2):235-245","DOI":"10.1007\/s00401-011-0900-5"},{"key":"ref=183","doi-asserted-by":"crossref","unstructured":"Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner HL, Khoury SJ.\u00a0Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: A cross-sectional observational study in patients with multiple sclerosis. PLoS One. 2014;9(7):e103716","DOI":"10.1371\/journal.pone.0103716"},{"key":"ref=184","doi-asserted-by":"crossref","unstructured":"Painter MM, Atagi Y, Liu CC, Rademakers R, Xu H, Fryer JD, et\u00a0al. TREM2\u00a0in CNS homeostasis and neurodegenerative disease. Molecular Neurodegeneration. 2015;10:43","DOI":"10.1186\/s13024-015-0040-9"},{"key":"ref=185","doi-asserted-by":"crossref","unstructured":"Kleinberger G, Yamanishi Y, Suarez-Calvet M, Czirr E, Lohmann E, Cuyvers E, et\u00a0al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Science Translational Medicine. 2014;6(243):243ra86","DOI":"10.1126\/scitranslmed.3009093"},{"key":"ref=186","doi-asserted-by":"crossref","unstructured":"Piccio L, Buonsanti C, Cella M, Tassi I, Schmidt RE, Fenoglio C, et\u00a0al. Identification of soluble TREM-2\u00a0in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation. Brain. 2008;131(Pt 11):3081-3091","DOI":"10.1093\/brain\/awn217"},{"key":"ref=187","doi-asserted-by":"crossref","unstructured":"Ohrfelt A, Axelsson M, Malmestrom C, Novakova L, Heslegrave A, Blennow K, et\u00a0al. Soluble TREM-2\u00a0in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone. Multiple Sclerosis. 2016;22(12):1587-1595","DOI":"10.1177\/1352458515624558"},{"key":"ref=188","doi-asserted-by":"crossref","unstructured":"Greenfield AL, Hauser SL.\u00a0B-cell therapy for multiple sclerosis: Entering an era. Annals of Neurology. 2018;83(1):13-26","DOI":"10.1002\/ana.25119"},{"key":"ref=189","doi-asserted-by":"crossref","unstructured":"Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, et\u00a0al. Ocrelizumab versus placebo in primary progressive multiple sclerosis. The New England Journal of Medicine. 2017;376(3):209-220","DOI":"10.1056\/NEJMoa1606468"},{"key":"ref=190","doi-asserted-by":"crossref","unstructured":"Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et\u00a0al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Science Translational Medicine. 2015;7(310):310ra166","DOI":"10.1126\/scitranslmed.aab4176"},{"key":"ref=191","doi-asserted-by":"crossref","unstructured":"Rao SP, Sancho J, Campos-Rivera J, Boutin PM, Severy PB, Weeden T, et\u00a0al. Human peripheral blood mononuclear cells exhibit heterogeneous CD52 expression levels and show differential sensitivity to alemtuzumab mediated cytolysis. PLoS One. 2012;7(6):e39416","DOI":"10.1371\/journal.pone.0039416"},{"key":"ref=192","doi-asserted-by":"crossref","unstructured":"Ambrose LR, Morel AS, Warrens AN.\u00a0Neutrophils express CD52 and exhibit complement-mediated lysis in the presence of alemtuzumab. Blood. 2009;114(14):3052-3055","DOI":"10.1182\/blood-2009-02-203075"},{"key":"ref=193","doi-asserted-by":"crossref","unstructured":"Baker D, Giovannoni G, Schmierer K.\u00a0Marked neutropenia: Significant but rare in people with multiple sclerosis after alemtuzumab treatment. Multiple Sclerosis and Related Disorders. 2017;18:181-183","DOI":"10.1016\/j.msard.2017.09.028"}],"container-title":["Multiple Sclerosis [Working Title]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.intechopen.com\/download\/pdf\/67198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,27]],"date-time":"2019-05-27T07:55:19Z","timestamp":1558943719000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.intechopen.com\/online-first\/myeloid-cells-in-multiple-sclerosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":193,"URL":"https:\/\/doi.org\/10.5772\/intechopen.86285","relation":{},"subject":[],"published":{"date-parts":[[2019,5,17]]}}}